Royce & Associates’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.9M | Sell |
772,360
-198,827
| -20% | -$2.29M | 0.09% | 321 |
|
|
2025
Q1 | $14.6M | Buy |
971,187
+2,059
| +0.2% | +$30.9K | 0.16% | 187 |
|
|
2024
Q4 | $16.8M | Sell |
969,128
-51,993
| -5% | -$900K | 0.16% | 186 |
|
|
2024
Q3 | $18.9M | Buy |
1,021,121
+84,022
| +9% | +$1.56M | 0.17% | 170 |
|
|
2024
Q2 | $19M | Sell |
937,099
-178,194
| -16% | -$3.62M | 0.18% | 162 |
|
|
2024
Q1 | $19M | Buy |
1,115,293
+201,019
| +22% | +$3.43M | 0.17% | 172 |
|
|
2023
Q4 | $16.1M | Buy |
914,274
+225,006
| +33% | +$3.97M | 0.15% | 192 |
|
|
2023
Q3 | $16.5M | Buy |
689,268
+72,476
| +12% | +$1.74M | 0.17% | 165 |
|
|
2023
Q2 | $14.3M | Sell |
616,792
-36,877
| -6% | -$857K | 0.14% | 207 |
|
|
2023
Q1 | $14.4M | Sell |
653,669
-85,094
| -12% | -$1.88M | 0.14% | 198 |
|
|
2022
Q4 | $15M | Buy |
+738,763
| New | +$15M | 0.16% | 177 |
|
|
2019
Q4 | – | Sell |
-77,500
| Closed | -$3.61M | – | 1143 |
|
|
2019
Q3 | $3.61M | Buy |
77,500
+2,500
| +3% | +$117K | 0.03% | 560 |
|
|
2019
Q2 | $3.92M | Hold |
75,000
| – | – | 0.04% | 550 |
|
|
2019
Q1 | $5.17M | Buy |
+75,000
| New | +$5.17M | 0.04% | 498 |
|
|
2015
Q3 | – | Sell |
-5,000
| Closed | -$570K | – | 1207 |
|
|
2015
Q2 | $570K | Sell |
5,000
-3,200
| -39% | -$365K | ﹤0.01% | 1073 |
|
|
2015
Q1 | $857K | Hold |
8,200
| – | – | ﹤0.01% | 1044 |
|
|
2014
Q4 | $987K | Buy |
+8,200
| New | +$987K | ﹤0.01% | 1075 |
|
|
2014
Q1 | – | Sell |
-100
| Closed | -$19K | – | 1420 |
|
|
2013
Q4 | $19K | Sell |
100
-17,600
| -99% | -$3.34M | ﹤0.01% | 1422 |
|
|
2013
Q3 | $3M | Hold |
17,700
| – | – | 0.01% | 970 |
|
|
2013
Q2 | $2.68M | Buy |
+17,700
| New | +$2.68M | 0.01% | 1001 |
|